Le Lézard
Classified in: Health

Cinesteam® Is a Deodorizing Support Tool for Palliative Care


Palliative Care Is a Comprehensive Approach to Long-Term Patient Care. Caregivers Can Use Cinesteam®'s Secondary Dressings to Improve Quality of Life in Palliative Care Settings.

FORT LAUDERDALE, Fla., April 29, 2024 /PRNewswire/ -- Palliative care is a key aspect of recovery for many patients. Unlike hospice care (which is designed to maintain comfort and quality of life for a terminally ill patient), palliative care seeks to ease discomfort during a lengthy medical procedure, complement a healing process, or help manage long-term medical symptoms.

Quality palliative care involves an interdisciplinary approach to treatment that considers the holistic needs of a patient. Mayo Clinic explains the various care techniques that can help with this, saying, "These may include breathing techniques, healing touch, meditation, visualization or simply listening to music with headphones." One aspect that is often left out of that list is wound care smell. Cinesteam® secondary dressings can play a key role in the process of managing these unwanted smells during long-term care.

"Many patients are unaware of the fact that malodorous wounds can create unpleasant odors?that is, until they're faced with the smells during recovery," explains Clémence Desjardin. The Director of Operations and Business Development at Cemag Care adds, "Once a wound begins creating a smell, it is in the best interest of a patient's quality of life for caregivers to ameliorate those symptoms. Our secondary dressings offer a quick, effective solution that uses a natural compound as its primary active ingredient."

Cinesteam® is a secondary dressing. (I.e., it is placed over a primary dressing and does not come in direct contact with a wound). The medical device contains an innovative design that features an adsorbent core and a cinnamon sachet that help to both capture unwanted volatile organic compounds (VOCs) and release cinnamon's own natural aroma in exchange. This effectively masks the smells of malodorous wounds. Regardless of whether those unwanted smells come from a fungating wound bed or an infected bed pressure ulcer, Cinesteam® helps maintain a higher quality of life for those in the midst of a lengthy round of palliative care.

About Cinesteam®:
Cinesteam® is a brand owned by a French pharmaceutical company based in Paris, Cemag Care, which was founded in 2016 by Dr André Ulmann. The brand is built on an innovative over-the-counter medical solution that uses a single natural ingredient (cinnamon) as a secondary dressing for those managing malodorous wounds from tumors, diabetic foot ulcers, pressure ulcers, and more. Cinesteam® effectively masks unwelcome odors and improves quality of life. (It does not heal the wound itself). The patented concept was developed from 2015 to 2019 and brought to market in Europe in 2020. NOTE: Cinesteam® is a class one medical device. Please read the instructions before use. Learn more at cinesteamcare.com and cemagcare.com.

Media Contact:
Clémence DESJARDIN, PhD
Business Development Manager

55 rue de Turbigo ? 75003 Paris ? France
Tel : +33 (0) 1 86 22 02 22
Mob: +33 (0) 6 63 04 32 77
Fax : +33 (0)1 73 79 35 54
email : [email protected]    

SOURCE Cinesteam


These press releases may also interest you

at 16:15
Quest Diagnostics , a leading provider of diagnostic information services, today announced that its Board of Directors has elected Robert (Rob) B. Carter, a seasoned technology executive, to serve as a director. Including Mr. Carter, the company's...

at 16:14
Just as Life Time continues to add to its portfolio of athletic country clubs across the nation ? now totaling more than 170 across 31 states and 43 major markets including Toronto ? the company is taking its commitment to inspire healthy, happy...

at 16:11
A new partnership between the Registered Nurses' Association of Ontario (RNAO) and the Indigenous Primary Health Care Council (IPHCC) aims to build a reciprocal relationship that fosters Indigenous representation at decision-making tables within RNAO...

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...

at 16:10
Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to a new employee. On May 14, 2024, the Compensation Committee of Savara's Board of Directors granted the...

at 16:10
CareDx, Inc. ? The Transplant Companytm ? a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers ? today...



News published on and distributed by: